Bioxytran, Inc. is a U.S.-based clinical-stage biotechnology company focused on developing innovative therapies for hypoxia-related conditions, viral infections, and degenerative diseases. The company leverages advanced carbohydrate-based drug design and galectin inhibitor technology to create treatments aimed at stroke, wound healing, and infectious diseases like COVID-19. Its pipeline includes promising drug candidates such as oxygen-carrying therapeutics, antiviral agents and anti-metastasis for cancer designed to address critical unmet medical needs and improve patient outcomes.
-
1 Yazı
-
1 Fotoğraflar
-
0 Videolar
-
Hayatımızda Needham
-
Kimden Needham
-
Ardından: 0 people
Son Güncellemeler
-
0 Yorumlar 0 hisse senetleri 50 Views 0 önizlemePlease log in to like, share and comment!
Daha Hikayeler